日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Survival prediction for pancreatic cancer patients receiving gemcitabine treatment

接受吉西他滨治疗的胰腺癌患者的生存预测

Matsubara, Junichi; Ono, Masaya; Honda, Kazufumi; Negishi, Ayako; Ueno, Hideki; Okusaka, Takuji; Furuse, Junji; Furuta, Koh; Sugiyama, Emiko; Saito, Yoshiro; Kaniwa, Nahoko; Sawada, Junichi; Shoji, Ayako; Sakuma, Tomohiro; Chiba, Tsutomu; Saijo, Nagahiro; Hirohashi, Setsuo; Yamada, Tesshi

Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment

建立了六株新的人类胆道癌细胞系,并将MAGEH1鉴定为预测吉西他滨治疗疗效的候选生物标志物

Ojima, Hidenori; Yoshikawa, Daitaro; Ino, Yoshihiro; Shimizu, Hiroko; Miyamoto, Masashi; Kokubu, Akiko; Hiraoka, Nobuyoshi; Morofuji, Noriaki; Kondo, Tadashi; Onaya, Hiroaki; Okusaka, Takuji; Shimada, Kazuaki; Sakamoto, Yoshihiro; Esaki, Minoru; Nara, Satoshi; Kosuge, Tomoo; Hirohashi, Setsuo; Kanai, Yae; Shibata, Tatsuhiro

Genome-wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stage

尿路上皮癌和癌前尿路上皮的全基因组DNA甲基化谱

Nishiyama, Naotaka; Arai, Eri; Chihara, Yoshitomo; Fujimoto, Hiroyuki; Hosoda, Fumie; Shibata, Tatsuhiro; Kondo, Tadashi; Tsukamoto, Taiji; Yokoi, Sana; Imoto, Issei; Inazawa, Johji; Hirohashi, Setsuo; Kanai, Yae

Intraductal carcinoma component as a favorable prognostic factor in biliary tract carcinoma

胆管癌中导管内癌成分是预后良好的因素

Ojima, Hidenori; Kanai, Yae; Iwasaki, Motoki; Hiraoka, Nobuyoshi; Shimada, Kazuaki; Sano, Tsuyoshi; Sakamoto, Yoshihiro; Esaki, Minoru; Kosuge, Tomoo; Sakamoto, Michiie; Hirohashi, Setsuo

Functional genome screen for therapeutic targets of osteosarcoma

骨肉瘤治疗靶点的功能基因组筛选

Yamaguchi, Umio; Honda, Kazufumi; Satow, Reiko; Kobayashi, Eisuke; Nakayama, Robert; Ichikawa, Hitoshi; Shoji, Ayako; Shitashige, Miki; Masuda, Mari; Kawai, Akira; Chuman, Hirokazu; Iwamoto, Yukihide; Hirohashi, Setsuo; Yamada, Tesshi

Large-scale quantitative clinical proteomics by label-free liquid chromatography and mass spectrometry.

利用无标记液相色谱和质谱法进行大规模定量临床蛋白质组学分析

Negishi Ayako, Ono Masaya, Handa Yasushi, Kato Hidenori, Yamashita Kohki, Honda Kazufumi, Shitashige Miki, Satow Reiko, Sakuma Tomohiro, Kuwabara Hideya, Omura Ken, Hirohashi Setsuo, Yamada Tesshi

Prolyl 4-hydroxylation of alpha-fibrinogen: a novel protein modification revealed by plasma proteomics

α-纤维蛋白原脯氨酰4-羟基化:血浆蛋白质组学揭示的一种新型蛋白质修饰

Ono, Masaya; Matsubara, Junichi; Honda, Kazufumi; Sakuma, Tomohiro; Hashiguchi, Tomoyo; Nose, Hiroshi; Nakamori, Shoji; Okusaka, Takuji; Kosuge, Tomoo; Sata, Naohiro; Nagai, Hideo; Ioka, Tatsuya; Tanaka, Sachiko; Tsuchida, Akihiko; Aoki, Tatsuya; Shimahara, Masashi; Yasunami, Yohichi; Itoi, Takao; Moriyasu, Fuminori; Negishi, Ayako; Kuwabara, Hideya; Shoji, Ayako; Hirohashi, Setsuo; Yamada, Tesshi

Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy.

NRF2 中的癌症相关突变会损害 Keap1-Cul3 E3 连接酶对其的识别,从而促进恶性肿瘤的发生

Shibata Tatsuhiro, Ohta Tsutomu, Tong Kit I, Kokubu Akiko, Odogawa Reiko, Tsuta Koji, Asamura Hisao, Yamamoto Masayuki, Hirohashi Setsuo

Wnt signaling inside the nucleus

细胞核内的Wnt信号传导

Shitashige, Miki; Hirohashi, Setsuo; Yamada, Tesshi

Molecular background of alpha-fetoprotein in liver cancer cells as revealed by global RNA expression analysis

通过全基因组RNA表达分析揭示肝癌细胞中甲胎蛋白的分子背景

Saito, Shigeru; Ojima, Hidenori; Ichikawa, Hitoshi; Hirohashi, Setsuo; Kondo, Tadashi